Breaking News Instant updates and real-time market news.

2022-05-18 17:03:58 DEN Denbury $66.64 / -3.08 (-4.42%) , NTR Nutrien $101.48 / -2.67 (-2.56%) 17:03 05/18/22 05/18 17:03 05/18/22 17:03	Denbury, Nutrien enter agreement for transportation and storage of CO2 Denbury Carbon Solutions, a wholly owned subsidiary of Denbury (DEN) and PCS Nitrogen Fertilizer, a wholly owned subsidiary of Nutrien (NTR) announced that the parties have reached a term-sheet agreement under which Denbury would transport and store carbon dioxide captured from Nutrien's potential new clean ammonia project at its Geismar, Louisiana location. Nutrien is evaluating its Geismar, Louisiana, ammonia facilities as a potential site for new ammonia production to serve growing demand in agriculture, industrial and emerging energy markets. Nutrien is progressing the proposed project to the front-end engineering design phase, with a final investment decision expected to follow in 2023 and, if approved, full production by 2027. The new plant is expected to have annual production capacity of 1.2M metric tons of clean ammonia, with approximately 1.8M metric tons per year of CO2 to be captured. Under the terms of the agreement, Nutrien would pay Denbury for the transportation and sequestration of the associated CO2 into Denbury's secure underground containment sites. The initial term of the agreement is 12 years, with up to two extension terms of five years each. DEN Denbury $66.64 / -3.08 (-4.42%) NTR Nutrien $101.48 / -2.67 (-2.56%)	18 May 01 Jun 04 Aug

2022-05-18 17:03:58

DEN

Denbury

$66.64 / -3.08 (-4.42%)

, NTR

Nutrien

$101.48 / -2.67 (-2.56%)

17:03

05/18/22

05/18

17:03

05/18/22

17:03

Denbury, Nutrien enter agreement for transportation and storage of CO2

Denbury Carbon Solutions, a wholly owned subsidiary of Denbury (DEN) and PCS Nitrogen Fertilizer, a wholly owned subsidiary of Nutrien (NTR) announced that the parties have reached a term-sheet agreement under which Denbury would transport and store carbon dioxide captured from Nutrien's potential new clean ammonia project at its Geismar, Louisiana location. Nutrien is evaluating its Geismar, Louisiana, ammonia facilities as a potential site for new ammonia production to serve growing demand in agriculture, industrial and emerging energy markets. Nutrien is progressing the proposed project to the front-end engineering design phase, with a final investment decision expected to follow in 2023 and, if approved, full production by 2027. The new plant is expected to have annual production capacity of 1.2M metric tons of clean ammonia, with approximately 1.8M metric tons per year of CO2 to be captured. Under the terms of the agreement, Nutrien would pay Denbury for the transportation and sequestration of the associated CO2 into Denbury's secure underground containment sites. The initial term of the agreement is 12 years, with up to two extension terms of five years each.

DEN

Denbury

$66.64 / -3.08 (-4.42%)

NTR

Nutrien

$101.48 / -2.67 (-2.56%)

18
May
01
Jun
04
Aug

OTHER BREAKING NEWS FROM THE FLY

Recommendations	UDR price target lowered to $48 from $60 at Mizuho » 07:59 06/27/22 06/27 07:59 06/27/22 07:59 UDR UDR $46.14 / +0.435 (+0.95%) Mizuho analyst Haendel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate UDR UDR $46.14 / +0.435 (+0.95%) 05/23/22 UDR names Joe Fisher as President and CFO UDR UDR $46.14 / +0.435 (+0.95%) 06/24/22 Truist UDR price target lowered to $50 from $53 at Truist 06/22/22 Credit Suisse UDR initiated with an Outperform at Credit Suisse 05/24/22 Truist UDR price target lowered to $53 from $61 at Truist 05/19/22 Scotiabank UDR price target lowered to $58 from $60 at Scotiabank UDR UDR $46.14 / +0.435 (+0.95%) 04/26/22 UDR raises FY22 AFFO view to $2.05-$2.11 from $2.02-$2.10, consensus $2.28 04/26/22 UDR sees Q2 AFFO 50c-52c 04/26/22 UDR reports Q1 AFFO 51c, consensus 55c 02/08/22 UDR sees FY AFFO $2.02-$2.10, consensus $2.26 30 Mar
Recommendations	MAA price target lowered to $178 from $221 at Mizuho » 07:59 06/27/22 06/27 07:59 06/27/22 07:59 MAA MAA $172.59 / +2.33 (+1.37%) Mizuho analyst Haendel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate MAA MAA $172.59 / +2.33 (+1.37%) 05/17/22 MAA increases dividend 15% to $1.25 MAA MAA $172.59 / +2.33 (+1.37%) 06/24/22 Truist MAA price target lowered to $188 from $205 at Truist 06/22/22 Credit Suisse MAA initiated with an Outperform at Credit Suisse 05/24/22 Truist MAA price target lowered to $205 from $220 at Truist 05/19/22 Scotiabank MAA price target lowered to $226 from $231 at Scotiabank MAA MAA $172.59 / +2.33 (+1.37%) 04/27/22 MAA raises FY22 core FFO view to $7.92-$8.24 from $7.74-$8.10, consensus $8.02 04/27/22 MAA still sees FY22 core FFO $6.95-$7.31, consensus $8.02 04/27/22 MAA reports Q2 core AFFO $1.85 vs. $1.54 a year ago 04/27/22 MAA reports Q1 core FFO $1.97, consensus $1.92 03 Aug
Hot Stocks	Imperial Oil receives acceptance from TSX to purchase up to 5% of shares » 07:59 06/27/22 06/27 07:59 06/27/22 07:59 IMO Imperial Oil $46.82 / +2 (+4.46%) , XOM Exxon Mobil $86.90 / +1.69 (+1.98%) Imperial Oil (IMO)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options IMO XOM IMO Imperial Oil $46.82 / +2 (+4.46%) 06/23/22 Imperial Oil and E3 Lithium in lithium pilot project pact in Alberta 06/13/22 Imperial Oil announces preliminary results of its substantial issuer bid 02/01/22 Imperial Oil increases quarterly dividend 26% to 34c per share XOM Exxon Mobil $86.90 / +1.69 (+1.98%) 06/22/22 President Biden calls on Congress to suspend federal gas tax 06/21/22 Exxon Mobil to hold 25% interest in new LNG joint venture in Qatar 06/15/22 Exxon Mobil 'in regular contact' with Biden administration on U.S. investments 05/25/22 Exxon Mobil says focused on five priorities to grow shareholder value IMO XOM IMO Imperial Oil $46.82 / +2 (+4.46%) 06/16/22 National Bank Imperial Oil price target raised to C$93 from C$80 at National Bank 06/16/22 RBC Capital Imperial Oil price target raised to C$78 from C$66 at RBC Capital 06/08/22 Scotiabank Imperial Oil price target raised to C$80 from C$72 at Scotiabank 05/12/22 RBC Capital Imperial Oil price target raised to C$66 from C$65 at RBC Capital XOM Exxon Mobil $86.90 / +1.69 (+1.98%) 06/21/22 Credit Suisse Exxon Mobil upgraded to Outperform from Neutral at Credit Suisse 06/07/22 Evercore ISI Evercore upgrades Exxon Mobil, sees 'achievable' path to doubling earnings 06/07/22 Credit Suisse Exxon Mobil price target raised to $115 from $102 at Credit Suisse 06/07/22 Evercore ISI Exxon Mobil upgraded to Outperform from In Line at Evercore ISI IMO XOM IMO Imperial Oil $46.82 / +2 (+4.46%) 02/01/22 Imperial Oil reports Q4 EPS C$1.18 vs (C$1.56) last year XOM Exxon Mobil $86.90 / +1.69 (+1.98%) 04/29/22 Exxon Mobil reports Q1 adjusted EPS $2.07, consensus $2.12 04/28/22 Notable companies reporting before tomorrow's open 04/28/22 Notable companies reporting before tomorrow's open 02/01/22 Exxon Mobil reports Q4 ex-items EPS $2.05, consensus $1.93 XOM XOM Exxon Mobil $86.90 / +1.69 (+1.98%) 06/15/22 Biden calls on oil refiners to boost supply of gas, diesel, CNBC reports 06/14/22 Finance chair to propose surtax on excessive oil company profits, Bloomberg says 06/10/22 Exxon, Chevron CEOs met with White House's Brian Deese, CNBC reports 06/10/22 Biden accuses U.S. oil industry of capitalizing on supply shortage, Reuters says XOM XOM Exxon Mobil $86.90 / +1.69 (+1.98%) 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 06/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/15/22 What You Missed On Wall Street On Wednesday XOM XOM Exxon Mobil $86.90 / +1.69 (+1.98%) 06/10/22 Early notable gainers among liquid option names on June 10th 06/08/22 Notable open interest changes for June 8th 06/07/22 Early notable gainers among liquid option names on June 7th 06/03/22 Early notable gainers among liquid option names on June 3rd
Recommendations	Essex Property Trust price target lowered to $273 from $342 at Mizuho » 07:59 06/27/22 06/27 07:59 06/27/22 07:59 ESS Essex Property Trust $261.65 / +2.06 (+0.79%) Mizuho analyst Haendel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ESS Essex Property Trust $261.65 / +2.06 (+0.79%) 02/24/22 Essex Property Trust raises annual dividend 5.3% ESS Essex Property Trust $261.65 / +2.06 (+0.79%) 06:04 Today Piper Sandler Essex Property Trust price target lowered to $340 from $400 at Piper Sandler 06/24/22 Truist Essex Property Trust price target lowered to $299 from $323 at Truist 06/22/22 Credit Suisse Essex Property Trust initiated with an Underperform at Credit Suisse 06/09/22 Stifel Essex Property Trust price target lowered to $352 from $390 at Stifel ESS Essex Property Trust $261.65 / +2.06 (+0.79%) 06/03/22 Essex Property Trust raises FY22 core FFO view to $14.00-$14.32 06/03/22 Essex Property Trust raises Q2 core FFO view to $3.55-$3.61 from $3.43-$3.55 04/26/22 Essex Property Trust sees FY22 core FFO $13.77-$14.13 from $13.46-$13.94 04/26/22 Essex Property Trust reports Q1 core FFO $3.37, consensus $3.34 ESS Essex Property Trust $261.65 / +2.06 (+0.79%) 06/06/22 What You Missed On Wall Street On Monday 06/06/22 What You Missed On Wall Street This Morning
Recommendations	Equity Residential price target lowered to $79 from $84 at Mizuho » 07:59 06/27/22 06/27 07:59 06/27/22 07:59 EQR Equity Residential $71.82 / -0.225 (-0.31%) Mizuho analyst Haendel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings EQR Equity Residential $71.82 / -0.225 (-0.31%) 06/24/22 Truist Equity Residential price target lowered to $79 from $85 at Truist 06/22/22 Credit Suisse Equity Residential initiated with an Outperform at Credit Suisse 06/22/22 RBC Capital RBC Capital upgrades Equity Residential to Outperform on coastal exposure 06/22/22 RBC Capital Equity Residential upgraded to Outperform from Sector Perform at RBC Capital EQR Equity Residential $71.82 / -0.225 (-0.31%) 04/26/22 Equity Residential sees Q2 normalized FFO 82c-86c 04/26/22 Equity Residential reports Q1 normalized FFO 77c, consensus 80c 02/01/22 Equity Residential sees FY22 normalized FFO $3.40-$3.50, consensus $3.32 02/01/22 Equity Residential sees Q1 normalized FFO 76c-80c

Recommendations	Camden Property price target lowered to $142 from $170 at Mizuho » 07:58 06/27/22 06/27 07:58 06/27/22 07:58 CPT Camden Property $135.13 / +0.53 (+0.39%) Mizuho analyst Haendel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate CPT Camden Property $135.13 / +0.53 (+0.39%) 04/04/22 Matador to replace Camden Property in S&P 400 at open on 4/4 04/04/22 Camden Property to replace People's United in S&P 500 at open on 4/4 03/29/22 Matador to replace Camden Property in S&P 400 at open on 4/4 03/29/22 Camden Property to replace People's United in S&P 500 at open on 4/4 CPT Camden Property $135.13 / +0.53 (+0.39%) 06/24/22 Truist Camden Property price target lowered to $149 from $160 at Truist 06/24/22 Baird Camden Property price target lowered to $153 from $175 at Baird 05/25/22 Truist Camden Property price target lowered to $160 from $186 at Truist 05/19/22 Scotiabank Camden Property price target lowered to $171 from $179 at Scotiabank CPT Camden Property $135.13 / +0.53 (+0.39%) 04/28/22 Camden Property sees Q2 FFO $1.60-$1.64 04/28/22 Camden Property raises FY22 FFO view to $6.39 - $6.63 from $6.09-$6.39 04/28/22 Camden Property reports Q1 AFFO $1.37, consensus $1.49 02/03/22 Camden Property sees Q1 FFO $1.45-$1.49, consensus $1.49 08 Apr
Recommendations	AvalonBay price target lowered to $212 from $260 at Mizuho » 07:58 06/27/22 06/27 07:58 06/27/22 07:58 AVB AvalonBay $195.14 / -1.415 (-0.72%) Mizuho analyst Haendel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly AVB AvalonBay $195.14 / -1.415 (-0.72%) 06/03/22 AvalonBay says two-month Same Store Residential rental revenue up 13% 04/05/22 PS Business Parks names Stephen Wilson as CEO, effective immediately 03/04/22 AvalonBay reports QTD same store residential rental revenue up 7.3% y/y 01/18/22 PS Business Parks names Stephen Wilson interim CEO AVB AvalonBay $195.14 / -1.415 (-0.72%) 06/24/22 Truist AvalonBay price target lowered to $224 from $263 at Truist 06/22/22 Credit Suisse AvalonBay initiated with a Neutral at Credit Suisse 05/19/22 Scotiabank AvalonBay price target lowered to $238 from $262 at Scotiabank 05/10/22 Barclays AvalonBay price target lowered to $229 from $263 at Barclays AVB AvalonBay $195.14 / -1.415 (-0.72%) 04/27/22 AvalonBay sees FY22 core FFO $9.38-$9.78, consensus $9.55 04/27/22 AvalonBay sees Q2 core FFO $2.25-$2.37 04/27/22 AvalonBay reports Q1 core FFO $2.26, consensus $2.26 02/02/22 AvalonBay sees FY22 core FFO $9.30-$9.80, consensus $9.39 07 Apr AVB AvalonBay $195.14 / -1.415 (-0.72%) 04/06/22 Fly Intel: After-Hours Movers
Recommendations	Apartment Income REIT price target lowered to $45 from $59 at Mizuho » 07:58 06/27/22 06/27 07:58 06/27/22 07:58 AIRC Apartment Income REIT $41.36 / +0.02 (+0.05%) Mizuho analyst Haendel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AIRC Apartment Income REIT $41.36 / +0.02 (+0.05%) 06/23/22 Westwater Resources CFO Jeffrey Vigil to retire, Steven Cates to succeed 03/28/22 Apartment Income REIT CFO sells $766K in common stock AIRC Apartment Income REIT $41.36 / +0.02 (+0.05%) 06/24/22 Truist Apartment Income REIT price target lowered to $45 from $49 at Truist 05/25/22 Truist Apartment Income REIT price target lowered to $49 from $58 at Truist 05/19/22 Scotiabank Apartment Income REIT price target lowered to $53 from $56 at Scotiabank 05/09/22 BTIG Apartment Income REIT initiated with a Neutral at BTIG AIRC Apartment Income REIT $41.36 / +0.02 (+0.05%) 05/02/22 Apartment Income REIT now sees FY FFO $2.37-$2.45, consensus $2.41 05/02/22 Apartment Income REIT reports Q1 FFO 57c, consensus 57c
Hot Stocks	Trump Media issues statement on Digital World Acquisition Corp. SEC filing » 07:55 06/27/22 06/27 07:55 06/27/22 07:55 DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) Trump Media &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Periodicals On The Fly Options DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 07:32 Today Digital World Acquisition says Garelick to resign from board 07:31 Today Trump-linked SPAC Digital World reports receipt of grand jury subpoena 06/15/22 Digital World Acquisition working toward consummating combination w/ Trump Media 06/13/22 Digital World Acquisition says SEC recently issued further subpoena DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 05/06/22 Truth Social CEO says Trump 'encouraged' Musk to buy Twitter, NYP reports 04/20/22 Digital World Acquisition named as short idea by Kerrisdale Capital 04/15/22 Fox News says didn't authorize account on Truth Social, Axios reports 04/12/22 Fox News is one of biggest brands to join Truth Social, Axios' Dan Primack says DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 05/18/22 #SocialStocks: Musk and Twitter working to close $44B deal, despite noise 05/16/22 What You Missed On Wall Street On Monday 05/16/22 What You Missed On Wall Street This Morning 05/01/22 Week in SPAC News: Trump-linked SPAC in spotlight as Musk buys Twitter DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 06/24/22 Largest borrow rate increases among liquid names 06/17/22 Digital World Acquisition Corp put volume heavy and directionally bearish 06/15/22 Unusually active option classes on open June 15th 06/13/22 Digital World Acquisition Corp put volume heavy and directionally bearish
Recommendations	Amedisys' Contessa finalizing '9-figure revenue contract,' says Jefferies » 07:51 06/27/22 06/27 07:51 06/27/22 07:51 AMED Amedisys $115.40 / +0.11 (+0.10%) After having hosted… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AMED Amedisys $115.40 / +0.11 (+0.10%) 06/24/22 Memorial Hermann, Contessa partner for new at-home care options 06/09/22 Amedisys releases inaugural ESG Report 06/09/22 Baylor Scott & White Health an Amedisy announce home care partnership 04/26/22 Amedisys promotes Muscato as Chief Strategy Officer AMED Amedisys $115.40 / +0.11 (+0.10%) 06/22/22 Benchmark Benchmark doesn't expect proposed Medicare home health cut to make final rule 06/21/22 BofA Amedisys cut to Underperform at BofA after CMS proposal on home health rates 06/21/22 BofA Amedisys downgraded to Underperform from Neutral at BofA 06/21/22 Deutsche Bank Amedisys price target lowered to $175 from $210 at Deutsche Bank AMED Amedisys $115.40 / +0.11 (+0.10%) 04/27/22 Amedisys sees FY22 adjusted EPS $5.23-$5.45, consensus $5.33 04/27/22 Amedisys reports Q1 adjusted EPS $1.23, consensus $1.12 02/23/22 Amedisys sees FY22 EPS $5.23-$5.45, consensus $5.84 02/23/22 Amedisys reports Q4 EPS $1.18, consensus $1.18

Hot Stocks	Cronos Group announces partnership with Geocann » 07:49 06/27/22 06/27 07:49 06/27/22 07:49 CRON Cronos Group $3.11 / +0.155 (+5.25%) Cronos Group announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CRON Cronos Group $3.11 / +0.155 (+5.25%) 06/21/22 Cronos Group, Ginkgo Bioworks announce achievement of THCV equity milestone 06/21/22 Ginkgo Bioworks and Cronos Group achieve THCV productivity milestone 03/21/22 Cronos Group founder Mike Gorenstein returns as CEO 03/01/22 Cronos Group announces planned exit of Peace Naturals Campus in Ontario CRON Cronos Group $3.11 / +0.155 (+5.25%) 05/11/22 CIBC CIBC upgrades Cronos to buy on 'multiple reasons for optimism' 05/11/22 Canaccord Cronos upgraded to Hold on operational improvements at Canaccord 05/11/22 CIBC Cronos Group upgraded to Outperformer from Neutral at CIBC 05/11/22 Canaccord Cronos Group upgraded to Hold from Sell at Canaccord CRON Cronos Group $3.11 / +0.155 (+5.25%) 05/10/22 Cronos Group reports Q1 EPS (9c), consensus (8c) 03/01/22 Cronos Group reports 2021 EPS ($1.07), consensus (47c) 02/18/22 Cronos Group reports Q3 EPS 21c, consensus (10c) CRON Cronos Group $3.11 / +0.155 (+5.25%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says CRON Cronos Group $3.11 / +0.155 (+5.25%) 06/23/22 Here's What You Missed in Cannabis This Week 06/16/22 Here's What You Missed in Cannabis This Week 06/09/22 Rising High: Exclusive talk with cannabis testing firm Green Scientific 06/02/22 Here's What You Missed in Cannabis This Week CRON Cronos Group $3.11 / +0.155 (+5.25%) 03/25/22 Unusually active option classes on open March 25th
Hot Stocks	Freyr announces Minister of Trade, Industry launched Norwegian battery strategy » 07:45 06/27/22 06/27 07:45 06/27/22 07:45 FREY Freyr Battery $6.93 / -0.005 (-0.07%) FREYR Battery welcomes… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options FREY Freyr Battery $6.93 / -0.005 (-0.07%) 06/15/22 Freyr Battery concludes raw material pacts to supply battery materials 05/25/22 Freyr Battery signs heads of terms for renewable power with Statkraft 05/18/22 Freyr Battery signs agreement with Vaasa for lease of 130 hectares of land 05/16/22 David Einhorn's Greenlight adds Southwestern, exits Sonos in Q1 FREY Freyr Battery $6.93 / -0.005 (-0.07%) 06/20/22 Goldman Sachs Freyr Battery initiated with a Neutral at Goldman Sachs 03/17/22 US Capital Advisors Freyr Battery initiated with a Buy at US Capital Advisors 01/26/22 Clarksons Platou Freyr Battery initiated with a Buy at Clarksons Platou 01/04/22 Morgan Stanley Ferrari replacing GM as Morgan Stanley's new 'Top Pick' in U.S. autos FREY Freyr Battery $6.93 / -0.005 (-0.07%) 05/11/22 Freyr Battery reports Q1 EPS (30c), consensus (14c) FREY Freyr Battery $6.93 / -0.005 (-0.07%) 06/15/22 Fly Intel: Pre-market Movers 01/19/22 Wall Street in Fives - Must Read Lists for Wednesday 01/19/22 Wall Street in Fives - Must Read Lists at Midday FREY Freyr Battery $6.93 / -0.005 (-0.07%) 04/28/22 FREYR Battery call volume above normal and directionally bullish
Conference/Events	Relay Therapeutics to hold virtual event » 07:45 06/27/22 06/27 07:45 06/27/22 07:45 RLAY Relay Therapeutics $20.87 / +1.87 (+9.84%) Virtual Investor and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events RLAY Relay Therapeutics $20.87 / +1.87 (+9.84%) 01/27/22 Relay Therapeutics treatment of cholangiocarcinoma granted orphan designation 01/04/22 Relay first patient dosed in trial of RLY-2608, initiates RLY-4008 expansion RLAY Relay Therapeutics $20.87 / +1.87 (+9.84%) 06/06/22 Jefferies Relay Therapeutics initiated with an Underperform at Jefferies 05/10/22 H.C. Wainwright Relay Therapeutics price target lowered to $47 from $54 at H.C. Wainwright 05/09/22 JMP Securities Relay Therapeutics price target lowered to $35 from $50 at JMP Securities 02/01/22 Berenberg Relay Therapeutics initiated with a Buy at Berenberg RLAY Relay Therapeutics $20.87 / +1.87 (+9.84%) 05/05/22 Relay Therapeutics reports Q1 EPS (57c), consensus (62c) 02/24/22 Relay Therapeutics reports Q4 EPS ($3.82), consensus (58c) 13 Oct 08:00 Today Relay Therapeutics
Recommendations	Altria Group price target lowered to $45 from $56 at Cowen » 07:43 06/27/22 06/27 07:43 06/27/22 07:43 MO Altria Group $43.41 / +0.905 (+2.13%) Cowen analyst Vivien Azer… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MO Altria Group $43.41 / +0.905 (+2.13%) 06/24/22 Juul to seek stay of FDA decision, exploring 'all options' under law 06/23/22 FDA denies authorization to market JUUL products 06/23/22 FDA denies authorization to market JUUL products 04/28/22 FDA proposes rules prohibiting menthol cigarettes and flavored cigars MO Altria Group $43.41 / +0.905 (+2.13%) 06/24/22 Morgan Stanley Altria Group upgraded to Equal Weight from Underweight at Morgan Stanley 06/22/22 Goldman Sachs Altria selloff overdone on potential FDA action on JUUL, says Goldman Sachs 06/22/22 Stifel Potential ban of JUUL vapor products 'clear negative' for Altria, says Stifel 06/22/22 Jefferies FDA lowered nicotine rule likely to take many years to implement, says Jefferies MO Altria Group $43.41 / +0.905 (+2.13%) 05/19/22 Altria Group backs FY22 adjusted EPS view $4.79-$4.93, consensus $4.86 04/28/22 Altria Group backs FY22 adjusted EPS $4.79-$4.93, consensus $4.84 04/28/22 Altria Group reports Q1 adjusted EPS $1.12, consensus $1.18 04/27/22 Notable companies reporting before tomorrow's open MO Altria Group $43.41 / +0.905 (+2.13%) 06/24/22 Appeals court halts FDA's ban on Juul e-cigarettes, AP reports 06/22/22 FDA to order Juul to take e-cigarettes off U.S. market, WSJ reports 06/21/22 Biden administration plans move to reduce nicotine in cigarettes, WaPo reports MO Altria Group $43.41 / +0.905 (+2.13%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/24/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/23/22 What You Missed On Wall Street On Thursday 07/28/22 Altria Group - MO MO Altria Group $43.41 / +0.905 (+2.13%) 06/23/22 Unusually active option classes on open June 23rd 06/22/22 Altria Group put volume heavy and directionally bearish 06/22/22 Unusually active option classes on open June 22nd 05/10/22 Unusually active option classes on open May 10th
Recommendations	Rockwell Automation price target lowered to $260 from $277 at Morgan Stanley » 07:42 06/27/22 06/27 07:42 06/27/22 07:42 ROK Rockwell Automation $201.07 / +3.735 (+1.89%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ROK Rockwell Automation $201.07 / +3.735 (+1.89%) 05/23/22 HP Inc. names Ernest Nicolas as chief supply chain officer 05/03/22 Rockwell Automation CEO: It was a tough quarter, below our expectations 05/03/22 Rockwell Automation falls -13.9% 05/03/22 Rockwell Automation board authorizes additional $1B for share repurchases ROK Rockwell Automation $201.07 / +3.735 (+1.89%) 05/24/22 Barclays Rockwell Automation price target lowered to $200 from $220 at Barclays 05/10/22 HSBC Rockwell Automation price target lowered to $240 from $293 at HSBC 05/05/22 JPMorgan Rockwell Automation price target lowered to $200 from $220 at JPMorgan 05/04/22 Oppenheimer Rockwell Automation price target lowered to $290 from $360 at Oppenheimer ROK Rockwell Automation $201.07 / +3.735 (+1.89%) 05/03/22 Rockwell cuts FY22 revenue growth view to 11% - 15% from 16% - 19% 05/03/22 Rockwell Automation cuts FY22 EPS view to $9.20 - $9.80 from $10.50 - $11.10 05/03/22 Rockwell Automation reports Q2 EPS $1.66, consensus $2.26 05/02/22 Notable companies reporting before tomorrow's open ROK Rockwell Automation $201.07 / +3.735 (+1.89%) 05/03/22 What You Missed On Wall Street On Tuesday 05/03/22 What You Missed On Wall Street This Morning 05/03/22 Fly Intel: Pre-market Movers 01/27/22 Wall Street in Fives - Must Read Lists for Thursday

Recommendations	Roche price target lowered to $48 from $58 at Cowen » 07:41 06/27/22 06/27 07:41 06/27/22 07:41 RHHBY Roche $41.64 / +1.63 (+4.07%) Cowen analyst Steve Scala… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events RHHBY Roche $41.64 / +1.63 (+4.07%) 06/16/22 FTC says to ramp up enforcement against illegal drug rebate schemes 06/16/22 Roche launches human papillomavirus self-sampling solution 06/16/22 Roche says crenezumab did not slow decline in autosomal dominant Alzheimer's 06/15/22 Roche announces FDA EUA for cobas SARS-CoV-2 Duo RHHBY Roche $41.64 / +1.63 (+4.07%) 06/02/22 Piper Sandler Piper ups Repare Therapeutics target after 'great deal' with Roche 05/19/22 Credit Suisse Roche price target lowered to CHF 350 from CHF 370 at Credit Suisse 05/13/22 Jefferies Roche downgraded to Hold from Buy at Jefferies 05/12/22 Morgan Stanley Roche price target lowered to CHF 370 from CHF 395 at Morgan Stanley RHHBY Roche $41.64 / +1.63 (+4.07%) 04/25/22 Roche reports Q1 group sales CHF 16.445B vs. CHF 14.93B last year 02/03/22 Roche sees FY22 core earnings growing in low- to mid-single digit range 02/03/22 Roche reports 2021 core EPS CHF 19.81 vs CHF 19.16 RHHBY Roche $41.64 / +1.63 (+4.07%) 02/24/22 Drugmakers criticize Medicare proposal on Biogen's Alzheimer's drug, WSJ says 02/09/22 Credit Suisse shareholders to block moves to extend Schwan's tenure, FT reports RHHBY Roche $41.64 / +1.63 (+4.07%) 06/02/22 What You Missed On Wall Street This Morning 01/13/22 Meet Prothena: Fly exclusive interview with CEO Gene Kinney 07/21/22 Roche - RHHBY
Hot Stocks	Accenture to acquire XtremeEDA, terms not disclosed » 07:39 06/27/22 06/27 07:39 06/27/22 07:39 ACN Accenture $299.36 / +13.3 (+4.65%) Accenture "has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options ACN Accenture $299.36 / +13.3 (+4.65%) 06/23/22 Johnson Controls, Accenture partner on OpenBlue Innovation Centers 06/23/22 Accenture raises FY22 negative FX impact view to 4.5% from 3% 06/23/22 Accenture sees FY22 operating cash flow $8.7B-$9.2B 06/06/22 Accenture acquires technology consultancy and managed services provider Advocate ACN Accenture $299.36 / +13.3 (+4.65%) 06/25/22 Barclays Accenture price target lowered to $370 from $455 at Barclays 06/24/22 RBC Capital Accenture price target lowered to $357 from $435 at RBC Capital 06/24/22 Cowen Accenture price target lowered to $325 from $330 at Cowen 06/24/22 Baird Accenture price target lowered to $310 from $340 at Baird ACN Accenture $299.36 / +13.3 (+4.65%) 06/23/22 Accenture sees Q4 revenue $15B-$15.5B, consensus $14.83B 06/23/22 Accenture narrows FY22 EPS view to $10.61-$10.70 from $10.61-$10.81 06/23/22 Accenture reports Q3 EPS $2.79, consensus $2.72 06/22/22 Notable companies reporting before tomorrow's open ACN Accenture $299.36 / +13.3 (+4.65%) 06/23/22 What You Missed On Wall Street On Thursday 06/23/22 What You Missed On Wall Street This Morning 06/23/22 Fly Intel: Pre-market Movers 03/17/22 What You Missed On Wall Street On Thursday 09/22/22 Accenture - ACN ACN Accenture $299.36 / +13.3 (+4.65%) 06/10/22 Accenture call volume above normal and directionally bullish 04/20/22 Largest borrow rate increases among liquid names
Recommendations	Merck price target raised to $102 from $95 at Cowen » 07:39 06/27/22 06/27 07:39 06/27/22 07:39 MRK Merck $93.22 / +1.14 (+1.24%) , SGEN Seagen $179.14 / +5.07 (+2.91%) Cowen analyst Boris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MRK SGEN MRK Merck $93.22 / +1.14 (+1.24%) 06:57 Today AstraZeneca, Merck announce LYNPARZA receives positive opinion from CHMP 06:18 Today AstraZeneca's Lynparza recommended for E.U. approval by CHMP in breast cancer 06/24/22 European Commission approves KEYTRUDA as adjuvant treatment for melanoma 06/24/22 Merck: EC approves KEYTRUDA for treatment of stage IIB or IIC melanoma SGEN Seagen $179.14 / +5.07 (+2.91%) 06/17/22 Seattle Genetics trading resumes 06/17/22 Seagen jumps 10% to $161.79 after WSJ report of Merck interest 06/17/22 Seattle Genetics trading halted, volatility trading pause 06/06/22 Seagen, Genmab present data from tisotumab vedotin clinical development program MRK SGEN MRK Merck $93.22 / +1.14 (+1.24%) 06/24/22 Mizuho Merck deal would add 'novel and validated technology,' says Mizuho 06/21/22 Oppenheimer Seagen price target raised to $208 from $160 at Oppenheimer 04/12/22 Barclays Merck price target raised to $97 from $94 at Barclays 04/11/22 H.C. Wainwright Rubius Therapeutics price target lowered to $15 from $40 at H.C. Wainwright SGEN Seagen $179.14 / +5.07 (+2.91%) 06/24/22 Mizuho Merck deal would add 'novel and validated technology,' says Mizuho 06/23/22 BMO Capital Seagen initiated with a Market Perform at BMO Capital 06/21/22 Morgan Stanley Seagen named 'Catalyst Driven Idea' at Morgan Stanley 06/21/22 Oppenheimer Seagen price target raised to $208 from $160 at Oppenheimer MRK SGEN MRK Merck $93.22 / +1.14 (+1.24%) 04/28/22 Merck raises FY22 adjusted EPS view to $7.24-$7.36, consensus $7.24 04/28/22 Merck reports Q1 adjusted EPS $2.14, consensus $1.83 04/27/22 Notable companies reporting before tomorrow's open 04/27/22 Notable companies reporting before tomorrow's open SGEN Seagen $179.14 / +5.07 (+2.91%) 04/28/22 Seagen sees FY22 total revenue $1.665B-$1.745B, consensus $1.78B 04/28/22 Seagen reports Q1 EPS (74c), consensus ($1.00) 02/10/22 Seagen sees FY22 total revenue $1.67B-$1.75B, consensus $2.16B 02/09/22 Seagen reports Q4 EPS (95c), consensus (83c) MRK SGEN MRK Merck $93.22 / +1.14 (+1.24%) 06/24/22 Merck moving forward with potential Seagen deal, WSJ reports 06/17/22 Merck, other suitors interested in acquiring Seagen, WSJ reports 06/17/22 Merck considering acquisition of Seagen, WSJ reports 05/31/22 Pfizer's Paxlovid becomes leading pandemic pill, WSJ reports SGEN Seagen $179.14 / +5.07 (+2.91%) 06/24/22 Merck moving forward with potential Seagen deal, WSJ reports 06/17/22 Merck, other suitors interested in acquiring Seagen, WSJ reports 06/17/22 Merck considering acquisition of Seagen, WSJ reports MRK SGEN MRK Merck $93.22 / +1.14 (+1.24%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/24/22 Fly Intel: Pre-market Movers 06/17/22 What You Missed On Wall Street On Friday SGEN Seagen $179.14 / +5.07 (+2.91%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/24/22 Fly Intel: Pre-market Movers 06/17/22 What You Missed On Wall Street On Friday 07/28/22 Merck - MRK 07/01/22 Extended PDUFA Date for Vaxneuvance 01/29/23 PDUFA Date for new sBLA for KEYTRUDA 10/04/22 Merck MRK MRK Merck $93.22 / +1.14 (+1.24%) 06/01/22 Merck put volume heavy and directionally bearish 05/31/22 Merck put volume heavy and directionally bearish 05/18/22 Merck put volume heavy and directionally bearish 04/04/22 Merck call buyer realizes 64% same-day gains
Hot Stocks	Clover's COVID vaccine candidate shows 'strong' neutralization against variant » 07:39 06/27/22 06/27 07:39 06/27/22 07:39 DVAX Dynavax $12.34 / +0.07 (+0.57%) China's Clover… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly DVAX Dynavax $12.34 / +0.07 (+0.57%) 05/17/22 Dynavax to replace Bottomline Technologies in S&P 600 at open on 5/17 05/12/22 Dynavax to replace Bottomline Technologies in S&P 600 at open on 5/17 02/28/22 Dynavax sees FY22 CpG 1018 adjuvant net product revenues of $550M 12/28/21 Dynavax notes Biological E's CORBEVAX received DCGI emergency use approval DVAX Dynavax $12.34 / +0.07 (+0.57%) 01/05/22 Goldman Sachs Goldman reinstates Dynavax at Buy, sees value creation from COVID platform 12/29/21 H.C. Wainwright Dynavax price target raised to $28 from $23 at H.C. Wainwright 08/31/21 H.C. Wainwright Dynavax price target raised to $23 from $20 at H.C. Wainwright 08/05/21 Goldman Sachs Dynavax initiated with a Buy at Goldman Sachs DVAX Dynavax $12.34 / +0.07 (+0.57%) 05/05/22 Dynavax still sees 2022 CpG 1018 adjuvant revenues at least $550M 05/05/22 Dynavax reports Q1 EPS 26c, consensus 24c 02/28/22 Dynavax reports Q4 EPS 55c, consensus 64c DVAX Dynavax $12.34 / +0.07 (+0.57%) 05/12/22 Fly Intel: After-Hours Movers
Hot Stocks	TG Therapeutics presents exploratory analyses from ublituximab in MS trial » 07:38 06/27/22 06/27 07:38 06/27/22 07:38 TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) TG Therapeutics … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) 06/03/22 TG Therapeutics announces data presentations from ULTIMATE I, II Phase 3 trials 05/31/22 TG Therapeutics announces FDA extension of BLA PDUFA date for ublituximab 04/15/22 TG Therapeutics withdraws leukemia application, pulls Ukoniq from sale 04/06/22 TG Therapeutics announces presentation of ULTIMATE I & II Phase 3 trial data TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) 06/13/22 B. Riley TG Therapeutics price target lowered to $17 from $23 at B. Riley 05/20/22 BofA BofA starts TG Therapeutics at Underperform, sees difficult commercial setup 05/20/22 BofA TG Therapeutics initiated with an Underperform at BofA 04/19/22 B. Riley TG Therapeutics application withdrawal 'clearing event,' says B. Riley TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) 03/01/22 TG Therapeutics reports Q4 EPS (70c), consensus (63c) TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) 04/18/22 What You Missed On Wall Street On Monday 04/18/22 What You Missed On Wall Street This Morning 01/27/22 Wall Street in Fives - Must Read Lists for Thursday 01/27/22 Wall Street in Fives - Must Read Lists at Midday TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) 06/09/22 Unusually active option classes on open June 9th 04/29/22 TG Therapeutics call volume above normal and directionally bullish

Recommendations	Televisa price target lowered to $13 from $15.50 at JPMorgan » 07:38 06/27/22 06/27 07:38 06/27/22 07:38 TV Televisa $8.71 / +0.34 (+4.06%) JPMorgan analyst Marcelo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research On The Fly TV Televisa $8.71 / +0.34 (+4.06%) 06/01/22 Goldman Sachs Televisa reinstated with a Neutral at Goldman Sachs 03/23/22 Barclays Televisa upgraded to Equal Weight from Underweight at Barclays 03/18/22 JPMorgan America Movil downgraded to Neutral from Overweight at JPMorgan 03/18/22 JPMorgan Televisa resumed with Overweight from Neutral at JPMorgan TV Televisa $8.71 / +0.34 (+4.06%) 03/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Recommendations	Copa Holdings price target lowered to $76 from $90 at JPMorgan » 07:38 06/27/22 06/27 07:38 06/27/22 07:38 CPA Copa Holdings $63.84 / +2.61 (+4.26%) JPMorgan analyst Fernando… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CPA Copa Holdings $63.84 / +2.61 (+4.26%) 06/10/22 Copa Holdings reports preliminary May traffic down 4.2%, capacity down 3.7% 05/10/22 Copa Holdings reports preliminary April traffic statistics 04/13/22 Copa Holdings reports preliminary March traffic statistics 03/10/22 Copa Holdings reports preliminary February traffic down 13% vs. 2019 CPA Copa Holdings $63.84 / +2.61 (+4.26%) 05/13/22 Barclays Barclays double upgrades Copa Holdings on improving operations 05/13/22 Barclays Copa Holdings upgraded to Overweight from Underweight at Barclays 04/13/22 Raymond James Copa Holdings price target lowered to $110 from $115 at Raymond James 02/23/22 Barclays Copa Holdings price target raised to $96 from $82 at Barclays CPA Copa Holdings $63.84 / +2.61 (+4.26%) 05/11/22 Copa Holdings reports Q1 EPS 47c, consensus 29c 02/09/22 Copa Holdings reports Q4 EPS ex-items $1.98, consensus 89c
Hot Stocks	DocGo to be added to Russell 2000 Index » 07:37 06/27/22 06/27 07:37 06/27/22 07:37 DCGO DocGo $7.11 / -0.39 (-5.20%) DocGo announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options DCGO DocGo $7.11 / -0.39 (-5.20%) 05/24/22 DocGo announces $40M share repurchase plan 05/17/22 DocGo expands mobile health services with Carnival 04/26/22 DocGo, Jefferson Health partner for patient transport 03/30/22 DocGo unit Ambulnz Community Partners awarded three 'sizeable' contracts DCGO DocGo $7.11 / -0.39 (-5.20%) 05/11/22 Canaccord DocGo price target lowered to $10 from $13 at Canaccord 04/19/22 Deutsche Bank DocGo initiated with a Buy at Deutsche Bank 01/19/22 Stifel DocGo initiated with a Buy at Stifel 01/04/22 Northland DocGo named a top pick for 2022 at Northland DCGO DocGo $7.11 / -0.39 (-5.20%) 05/09/22 DocGo backs FY22 revenue view $400M-$420M, consensus $410.59M 05/09/22 DocGo reports Q1 EPS 9c, consensus 4c 03/14/22 DocGo sees FY22 revenue $400M-$420M, consensus $385.2M 03/14/22 DocGo reports Q4 net income $20.3M vs. ($4.4M) last year DCGO DocGo $7.11 / -0.39 (-5.20%) 01/11/22 Nine new option listings on January 11th
Hot Stocks	BridgeBio announces data for for BBP-711 to treat recurrent kidney stone formers » 07:35 06/27/22 06/27 07:35 06/27/22 07:35 BBIO BridgeBio $9.24 / +0.175 (+1.93%) BridgeBio Pharma … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options BBIO BridgeBio $9.24 / +0.175 (+1.93%) 06/22/22 BridgeBio announces early data for BBP-812 06/17/22 Atai Life Sciences says Stephen Bardin to be named CFO in Q3 06/13/22 BridgeBio shares data from Phase 2b trial of encaleret 06/10/22 BridgeBio affiliate Venthera presents preliminary results from VT30 trial BBIO BridgeBio $9.24 / +0.175 (+1.93%) 03/16/22 H.C. Wainwright BridgeBio price target lowered to $22 from $24 at H.C. Wainwright 03/11/22 JPMorgan BridgeBio price target lowered to $18 from $21 at JPMorgan 01/03/22 Piper Sandler Alnylam upgraded to Overweight from Neutral at Piper Sandler 12/30/21 BofA Alnylam remains top pick for 2022 at Bofa amid recent volatility BBIO BridgeBio $9.24 / +0.175 (+1.93%) 05/05/22 BridgeBio reports Q1 EPS ($1.35), consensus ($1.11) 02/24/22 BridgeBio reports Q4 EPS ($1.01), consensus (87c) BBIO BridgeBio $9.24 / +0.175 (+1.93%) 05/12/22 Fly Intel: Pre-market Movers 12/27/21 Wall Street in Fives - Must Read Lists for Monday 12/27/21 Wall Street in Fives - Must Read Lists at Midday 12/27/21 Fly Intel: Pre-market Movers BBIO BridgeBio $9.24 / +0.175 (+1.93%) 01/03/22 Unusually active option classes on open January 3rd 12/28/21 Unusually active option classes on open December 28th
Downgrade	Morgan Stanley downgrades Varonis to Equal Weight on slowing topline growth » 07:35 06/27/22 06/27 07:35 06/27/22 07:35 VRNS Varonis $34.92 / +2.04 (+6.20%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly VRNS Varonis $34.92 / +2.04 (+6.20%) 06/15/22 Varonis announces new features for cloud security offering 05/25/22 Varonis achieves Cloud Security Alliance STAR Certfication 04/26/22 Varonis announces features for securing sensitive data in Salesforce 01/25/22 Varonis announces Version 8.6 of the Varonis Data Security Platform VRNS Varonis $34.92 / +2.04 (+6.20%) 05:34 Today Morgan Stanley Varonis downgraded to Equal Weight from Overweight at Morgan Stanley 05/23/22 Jefferies Varonis price target lowered to $40 from $65 at Jefferies 05/10/22 Truist Varonis price target lowered to $50 from $65 at Truist 05/03/22 Wedbush Varonis price target lowered to $52 from $60 at Wedbush VRNS Varonis $34.92 / +2.04 (+6.20%) 05/02/22 Notable companies reporting after market close 02/07/22 Varonis sees FY22 EPS 16c-17c, consensus 22c 02/07/22 Varonis sees Q1 EPS (11c)-(10c), consensus (6c) 02/07/22 Varonis reports Q4 EPS 16c, consensus 13c VRNS Varonis $34.92 / +2.04 (+6.20%) 05/02/22 Fly Intel: After-Hours Movers 04/26/22 What Wall Street is saying about Alphabet ahead of earnings

Events

Earnings calls, analyst events, roadshows and more

RLAY
Today at 08:00

Relay Therapeutics Firm Sponsored Meetings

Virtual Meeting
THO
Today at 09:00

Thor Industries Firm Sponsored Meetings

Airstream Headquarters, Jackson Center, OH
Today at 09:00

Technology/EV Supply Chain Industry Meetings
QRTEA
Today at 09:30

Qurate Retail Firm Sponsored Meetings

Virtual Meeting
NPSNY
Today at 10:00

Naspers - NPSNY Conference Calls
Today at 10:00

Consumer Industry Meetings
DELL
Today at 10:30

Dell Technologies Inc. CL C Firm Sponsored Meetings
UTHR
Today at 10:30

United Therapeutics Corporation Firm Sponsored Meetings
ORGN
Today at 11:00

Origin Materials Inc. Firm Sponsored Meetings
NTAP
Today at 11:30

NetApp - NTAP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	IE X IE Ivanhoe Electric IPO Managers: BMO Capital & Jefferies, JPMorgan, Raymond James, RBC Capital, Scotiabank $11.75-12.50 14.388M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TUYA X TUYA Tuya Secondary Managers: CICC, BofA, Morgan Stanley & CMBI $2.30 7.3M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Denbury, Nutrien enter agreement for transportation and storage of CO2

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access